Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Price / Earnings (ltm)

Amag Pharmaceuticals Price / Earnings (ltm) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Price / Earnings (ltm) from 2015 to 2017. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Amag Pharmaceuticals Price / Earnings (ltm) for the quarter ending February 02, 2017 was 52.13 a -1.32% decrease of -0.69 year over year
  • Amag Pharmaceuticals Price / Earnings (ltm) for the last 12 months ending February 02, 2017 was 52.13 a -1.32% decrease of -0.69 year over year
  • Amag Pharmaceuticals Annual Price / Earnings (ltm) for 2017 was 52.13 a -2.42% decrease of -1.26 from 2016
  • Amag Pharmaceuticals Annual Price / Earnings (ltm) for 2017 was 53.39 a -0.65% decrease of -0.34 from 2016
  • Amag Pharmaceuticals Annual Price / Earnings (ltm) for 2017 was 53.74 a 1.71% increase of 0.92 from 2016
Other Valuation Metrics:
  • Amag Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $687m a 6.12% increase of 42m year over year
  • Amag Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 0.87 a 21.08% increase of 0.18 year over year
  • Amag Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,093m a 1.93% increase of 21m year over year
View Chart On Koyfin

Quarterly AMAG Price / Earnings (ltm) Data

02/201752.13
02/201753.39
02/201753.74
02/201752.82
02/201750.87
02/201750.64
02/201750.75
02/201749.83
02/201753.85
01/201755.35

Annual AMAG Price / Earnings (ltm) Data

201752.13
201753.39
201753.74
201752.82
201750.87
201750.64
201750.75
201749.83
201753.85
201755.35